Role of p53 in Anticancer Drug Treatment- and Radiation-Induced Injury in Normal Small Intestine

In the human gastrointestinal tract, the functional mucosa of the small intestine has the highest capacity for absorption of nutrients and rapid proliferation rates, making it vulnerable to chemoradiotherapy. Recent understanding of the protective role of p53-mediated cell cycle arrest in the small...

Full description

Bibliographic Details
Main Author: Shi Jin
Format: Article
Language:English
Published: China Anti-Cancer Association 2012-03-01
Series:Cancer Biology & Medicine
Subjects:
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/1/575
_version_ 1818981904241655808
author Shi Jin
author_facet Shi Jin
author_sort Shi Jin
collection DOAJ
description In the human gastrointestinal tract, the functional mucosa of the small intestine has the highest capacity for absorption of nutrients and rapid proliferation rates, making it vulnerable to chemoradiotherapy. Recent understanding of the protective role of p53-mediated cell cycle arrest in the small intestinal mucosa has led researchers to explore new avenues to mitigate mucosal injury during cancer treatment. A traditional p53 inhibitor and two other molecules that exhibit strong protective effects on normal small intestinal epithelium during anticancer drug treatment and radiation therapy are introduced in this work. The objective of this review was to update current knowledge regarding potential mechanisms and targets that inhibit the side effects induced by chemoradiotherapy.
first_indexed 2024-12-20T17:38:44Z
format Article
id doaj.art-95202ee38ce44112b551f0696b303e3a
institution Directory Open Access Journal
issn 2095-3941
language English
last_indexed 2024-12-20T17:38:44Z
publishDate 2012-03-01
publisher China Anti-Cancer Association
record_format Article
series Cancer Biology & Medicine
spelling doaj.art-95202ee38ce44112b551f0696b303e3a2022-12-21T19:31:10ZengChina Anti-Cancer AssociationCancer Biology & Medicine2095-39412012-03-01911810.7497/j.issn.2095-3941.2012.01.001Role of p53 in Anticancer Drug Treatment- and Radiation-Induced Injury in Normal Small IntestineShi JinIn the human gastrointestinal tract, the functional mucosa of the small intestine has the highest capacity for absorption of nutrients and rapid proliferation rates, making it vulnerable to chemoradiotherapy. Recent understanding of the protective role of p53-mediated cell cycle arrest in the small intestinal mucosa has led researchers to explore new avenues to mitigate mucosal injury during cancer treatment. A traditional p53 inhibitor and two other molecules that exhibit strong protective effects on normal small intestinal epithelium during anticancer drug treatment and radiation therapy are introduced in this work. The objective of this review was to update current knowledge regarding potential mechanisms and targets that inhibit the side effects induced by chemoradiotherapy.http://www.cancerbiomed.org/index.php/cocr/article/view/1/575chemotherapygenesp53DNA damagesmall intestine
spellingShingle Shi Jin
Role of p53 in Anticancer Drug Treatment- and Radiation-Induced Injury in Normal Small Intestine
Cancer Biology & Medicine
chemotherapy
genes
p53
DNA damage
small intestine
title Role of p53 in Anticancer Drug Treatment- and Radiation-Induced Injury in Normal Small Intestine
title_full Role of p53 in Anticancer Drug Treatment- and Radiation-Induced Injury in Normal Small Intestine
title_fullStr Role of p53 in Anticancer Drug Treatment- and Radiation-Induced Injury in Normal Small Intestine
title_full_unstemmed Role of p53 in Anticancer Drug Treatment- and Radiation-Induced Injury in Normal Small Intestine
title_short Role of p53 in Anticancer Drug Treatment- and Radiation-Induced Injury in Normal Small Intestine
title_sort role of p53 in anticancer drug treatment and radiation induced injury in normal small intestine
topic chemotherapy
genes
p53
DNA damage
small intestine
url http://www.cancerbiomed.org/index.php/cocr/article/view/1/575
work_keys_str_mv AT shijin roleofp53inanticancerdrugtreatmentandradiationinducedinjuryinnormalsmallintestine